DMI-Logo
search-iconsearch-icon

Others Research Reports & Consulting

Home
>
Reports
>
Pharmaceuticals
>
Others
Browse reports
DataM has exclusive market relevance and knowledge catering our services in 60+ industries
SUB CATEGORIES
All PharmaceuticalsCardiovascularCentral Nervous SystemDermatologyEar Nose Throat DisordersGastrointestinalGenitourinary DisordersHematologyHormonal DisordersImmunologyInfectious DiseaseMetabolic DisorderDiabetes CareMouth And Dental DisordersPain ManagementMusculoskeletalNeurologyNon-Malignant DisordersNutritional DisordersOncologyOphthalmologyOther DiseasesAllergyRespiratoryWomen's and Male HealthWound Care TreatmentSyndromeOthers
FILTER
Geography
Publish Date
Themesdown
SORT
Upload Date
Upload Date
Price
Published: 2026 July 17
Glutaminyl Cyclase Inhibitor Therapy Market Size, Share, Trends and Forecast 2026-2035
Glutaminyl cyclase inhibitor therapy market was pre-commercial in 2025 and is projected to reach US$1.76 billion by 2035 as QPCT and QPCTL therapies advance toward commercialization.
Starting from
$4350$2999
Published: 2026 July 14
PARP Inhibitors Market Size, Share, Industry, Forecast and outlook 2026-2033
PARP Inhibitors Market reached US$ 4.14 billion in 2025 and is expected to reach US$ 7.84 billion by 2033
Starting from
$4350$2999
Published: 2026 July 14
Global Multispecific Antibodies Market - Size, Share, and Forecast (2026-2035)
The global multispecific antibodies market was valued at USD 15.87 billion in 2025 and is projected to reach USD 125.11 billion by 2035, growing at a CAGR of 25.9% during the forecast period (2026–2035).
Starting from
$4350$2999
Published: 2026 July 14
Neurofibromatosis Type 1 (NF1) Market Size, Share, Trends and Forecast 2026-2035
Neurofibromatosis type 1 market reached US$ 8.35 billion in 2025 and is projected to reach US$ 21.42 billion by 2035, growing at a 9.9% CAGR.
Starting from
$4350$2999
Published: 2026 July 12
Japan Compounded Sterile Preparations Market Size, Share and Forecast 2033
Japan Compounded Sterile Preparations Market reached to 137.39 million in 2025 and is expected to reach US$227.37 Million by 2033
Starting from
$3175$2189
Published: 2026 July 12
Primary Biliary Cholangitis Treatment Market Size, Share, Therapy Trends and Forecast 2026-2035
Primary Biliary Cholangitis Treatment Market size was at US$ 958.84 million in 2025 and is expected to reach US$ 1991.17 Mn by 2035, growing with a CAGR of 7.7%.
Starting from
$4350$2999
Published: 2026 July 10
Inflammatory Diseases Biologics Market Size, Share, Growth and Forecast to 2035
Global inflammatory diseases biologics market valued at US$ 104.31 BN in 2025 is projected to reach USD 157.31BN by 2033 (5.3% CAGR). Growth driven by expanding indications, biosimilar launches, and rising autoimmune disease prevalence.
Starting from
$4350$2999
Published: 2026 July 10
IL-27 Antagonist Therapy Market Size, Share, Trends and Forecast 2026-2035
IL-27 antagonist therapy market remained pre-commercial in 2025 and is projected to reach US$1.12 billion by 2035 as IL-27-targeted immunotherapies advance toward commercialization.
Starting from
$4350$2999
Published: 2026 July 08
VEGFR Inhibitors Market Size, Drug Landscape, Pipeline & Forecast 2035
VEGFR inhibitors market will reach US$25.07 billion by 2035 at a 5.9% CAGR. Explore VEGFR TKIs, cancer indications, pipeline, regional trends and companies.
Starting from
$4350$2999
Published: 2026 July 08
Precocious Puberty Treatment Market Size, Share, Industry, Forecast and Outlook (2026-2031)
Precocious Puberty Treatment Market Expected to reach a CAGR of 7.6% by 2031: DataM Intelligence
Starting from
$4350$2999